Rep. Josh Gottheimer Sells Unicharm (OTCMKTS:UNICY) Shares

Representative Josh Gottheimer (D-New Jersey) sold shares of Unicharm (OTCMKTS:UNICY) valued between $1,001 and $15,000 on May 14th, as disclosed in a filing on June 11th. The transaction occurred in his Morgan Stanley account. Unicharm's stock recently traded at $3.57, with a market cap of $10.47 billion and a PE ratio of 17.85. The company reported $0.05 EPS for the last quarter, with revenue of $1.49 billion, below analyst estimates of $1.69 billion.

Representative Josh Gottheimer (D-New Jersey) recently sold shares of Unicharm OTCMKTS: UNICY. In a filing disclosed on June 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in Unicharm stock on May 14th. The trade occurred in the Representative's "MORGAN STANLEY - SELECT UMA ACCOUNT # 1" account.

Representative Josh Gottheimer also recently made the following trade(s):

Sold $1,001 - $15,000 in shares of Visa NYSE: V on 6/26/2025.
Sold $1,001 - $15,000 in shares of Visa NYSE: V on 6/25/2025.
Purchased $1,001 - $15,000 in shares of Broadcom NASDAQ: AVGO on 6/25/2025.
Sold $1,001 - $15,000 in shares of ConocoPhillips NYSE: COP on 6/24/2025.
Purchased $1,001 - $15,000 in shares of NVIDIA NASDAQ: NVDA on 6/24/2025.
Sold $1,001 - $15,000 in shares of Visa NYSE: V on 6/24/2025.
Sold $1,001 - $15,000 in shares of Visa NYSE: V on 6/20/2025.
Purchased $1,001 - $15,000 in shares of Cloudflare NYSE: NET on 6/20/2025.
Purchased $1,001 - $15,000 in shares of Carvana NYSE: CVNA on 6/20/2025.
Sold $1,001 - $15,000 in shares of McDonald's NYSE: MCD on 6/20/2025.

Unicharm Stock Performance

Shares of Unicharm stock traded up $0.12 during trading on Wednesday, hitting $3.57. 110,274 shares of the stock were exchanged, compared to its average volume of 549,101. The stock's fifty day moving average is $3.80 and its 200 day moving average is $3.99. Unicharm has a 12 month low of $3.29 and a 12 month high of $8.10. The stock has a market cap of $10.47 billion, a PE ratio of 17.85 and a beta of 0.25. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.86 and a current ratio of 2.31.

Unicharm (OTCMKTS:UNICY - Get Free Report) last posted its quarterly earnings results on Friday, May 9th. The company reported $0.05 earnings per share (EPS) for the quarter. The business had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.69 billion. As a group, sell-side analysts anticipate that Unicharm will post 0.17 EPS for the current year.

About Representative Gottheimer

Josh Gottheimer (Democratic Party) is a member of the U.S. House, representing New Jersey's 5th Congressional District. He assumed office on January 3, 2017. His current term ends on January 3, 2027. Gottheimer (Democratic Party) is running for re-election to the U.S. House to represent New Jersey's 5th Congressional District. He declared candidacy for the 2026 election. Gottheimer is also running for election for Governor of New Jersey. He declared candidacy for the Democratic primary scheduled on June 10, 2025. Gottheimer attended the University of Pennsylvania for his undergraduate degree. He became a Thouron Fellow at Oxford and attended Harvard Law School. Gottheimer worked as a speech writer under former President Bill Clinton (D), assisting with two State of the Union addresses, among other projects. Before running for Congress, he worked for Microsoft as a general manager for corporate strategy.

About Unicharm

(Get Free Report)

Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand.

Featured Articles

Five stocks we like better than Unicharm
3 Small Caps With Big Return Potential
Intuitive Surgical Crushes Q2 Expectations, So Why No Rally?
3 Grocery Stocks That Are Proving They Are Still Essential
The Bottom Is in for Kohl’s, But Let the Share Price Come to You
Asset Allocation Strategies in Volatile Markets
Coca-Cola Q2 Margins Rise; Is KO Stock Undervalued?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Unicharm Right Now?

Before you consider Unicharm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unicharm wasn't on the list.

While Unicharm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here